Gsa Capital Partners LLP Axogen, Inc. Transaction History
Gsa Capital Partners LLP
- $1.35 Billion
- Q4 2024
A detailed history of Gsa Capital Partners LLP transactions in Axogen, Inc. stock. As of the latest transaction made, Gsa Capital Partners LLP holds 14,033 shares of AXGN stock, worth $247,261. This represents 0.02% of its overall portfolio holdings.
Number of Shares
14,033Holding current value
$247,261% of portfolio
0.02%Shares
6 transactions
Others Institutions Holding AXGN
# of Institutions
178Shares Held
36.5MCall Options Held
230KPut Options Held
400-
First Light Asset Management, LLC Edina, MN4.09MShares$72.1 Million5.0% of portfolio
-
Black Rock Inc. New York, NY3.25MShares$57.3 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT3.01MShares$53 Million3.58% of portfolio
-
Morgan Stanley New York, NY2.9MShares$51.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.43MShares$42.7 Million0.0% of portfolio
About Axogen, Inc.
- Ticker AXGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 42,283,700
- Market Cap $745M
- Description
- AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...